News Releases

Decade of TMV research leads to never-before-seen microsystems for energy storage, biosensors and self-sustaining systems


June 21, 2017 -- Since 2007, University of Maryland professors Reza Ghodssi (Electrical and Computer Engineering and Institute for Systems Research) and James Culver (Plant Sciences and Landscape Architecture and Institute of Bioscience and Biotechnology Research) have partnered with colleagues from materials science, chemistry and bioengineering to create devices using the Tobacco mosaic virus as a biological nanoscaffold. The work has resulted in never-before-possible microsystems for energy storage and biological sensors.

IBBR Awarded $6 Million NIH Grant for Structure-Based Design of a Hepatitis C Vaccine


(Rockville, MD, June 12, 2017) The Institute for Bioscience and Biotechnology Research (IBBR) has been awarded a $6.0 million grant entitled, “Structure-Based Vaccine Design for Hepatitis C Virus”, to develop a novel prophylactic vaccine to prevent hepatitis C virus (HCV) infection. The grant is funded by the National Institutes of Health (NIH) and the research will take place over a five-year period.  

IBBR faculty win two Maryland Innovation Initiative (MII) grants


(Rockville, MD, June 5, 2017) The Institute for Bioscience and Biotechnology Research (IBBR) has been awarded two $115,000 grants to commercialize technologies based on improving protein-based therapeutics utilizing a novel biopolymer and an alternate way to treat Niemann-Pick disease patients. The grants are funded by the Maryland Innovation Initiative (MII) as part of the Technology Council of Maryland’s (TEDCO) effort to support commercialization of academic-based scientific research and the state’s efforts to foster economic development in Maryland. 

Genisphere Begins Collaborative and Sponsored Research Program with the University of Maryland


HATFIELD, Pa - April 26, 2017 - Genisphere LLC, provider of the 3DNA® drug delivery platform, has signed a collaborative and sponsored research agreement with the University of Maryland, through Dr. Silvia Muro. The overall goal of the partnership is to study the pharmacokinetics and pharmacodynamics of various 3DNA designs and formulations after in vivo administration. Additional aims involve targeting diseases of the vasculature as well as inflammatory responses, demonstrating various methods of endocytosis via appropriate targeting moieties, and studying the... Read More

IBBR Receives Award to Develop Drought-Tolerant Plants


(Rockville, Maryland) The Institute for Bioscience and Biotechnology Research has been awarded a $100,000 grant to test the broader applicability of a technology platform invented by one of its leading scientists towards engineering drought-tolerant, agriculturally important crops.  The grant is funded by the Maryland Innovation Initiative (MII) as part of the Technology Council of Maryland’s (TEDCO) effort to support commercialization of academic-based scientific research as part of the state’s efforts to foster economic development in Maryland.

IBBR Fellow, Shunyuan Xiao, Ph.D.,... Read More

Bentley Leads Team of Researchers Working to Develop Electrogenetic Device for Activating Gene Expression via Electrodes


FOR IMMEDIATE RELEASE   
                                               

Media Contact: Alyssa Wolice, 301-405-3936
 

UMD Researchers Develop Electrogenetic Device for Activating Gene Expression via Electrodes

System Holds Promise for Study of Biological Systems, Biosensors and Bio-hybrid Devices

 

College Park, Md. – Researchers from the University of Maryland (UMD) are working to develop an electrogenetic device to direct gene expression, an achievement that holds promise for... Read More

IBBR Scientist Brian Pierce Wins Best Inventor Pitch at UMD's Bioscience Day 2016


By Tiffany Stone

At the University of Maryland’s Bioscience Day 2016, Brian Pierce, PhD., Assistant Professor, Institute for Bioscience and Biotechnology Research (IBBR), presented new rational design approaches to develop hepatitis C vaccines, winning the best inventor pitch. Pierce received a $3,000 award sponsored by UM Ventures, a joint initiative of the MPowering the State Program, that brings together the University of Maryland, Baltimore and University of Maryland, College Park to commercialize technology.

Pierce garnered the award at the Professor Venture... Read More

IBBR Scientist's Remarkable Discovery Premiers in Two Publications


By Tiffany Stone

FRONT COVER OF IMMUNITY, April 19, 2016

THE JOURNAL OF IMMUNOLOGY, MAY 1, 2016

Yuxing Li, PhD, IBBR Associate Professor, led a groundbreaking study that was spotlighted on the front cover of Immunity, a renowned scientific publication. The research identified an antibody in its intermediate maturation stage whose mature form was found in a powerful class of molecules effective against HIV. Knowledge of the anti-HIV antibodies’ evolution and how it develops could be the key to developing a vaccine... Read More

Muro Develops Technique to Improve Oral Drug Delivery Using Targeted Nanocarriers


© Advanced Functional Materials
http://onlinelibrary.wiley.com/doi/10.1002/adfm.v26.20/issuetoc
 

Associate Professor Silvia Muro, PhD and fellow UMD researchers are working to improve oral drug delivery to targets by protecting against the effects of gastric conditions.

For decades, scientists have worked to target therapeutics to specific markers within the body in efforts to improve delivery of medication to the target site while avoiding interaction with healthy tissue. But, the... Read More

Chinese Delegation Visits IBBR


By Tiffany Stone

A delegation of Chinese entrepreneurs and investors visited the Institute for Bioscience and Biotechnology Research as part of a two-week-long tour to the U.S. They were here to visit universities that are leaders in the biotechnology and biomedicine fields.  The group was interested in learning more about cutting-edge scientific research and latest breakthroughs, as well as seeking out potential investment opportunities.

They showed a strong interest in IBBR’s mission and unique ability to leverage technologies and expertise across its partner... Read More